111 related articles for article (PubMed ID: 37659581)
41. Impact of Early Palliative Care on End-of-Life Outcomes in Hematologic Malignancies.
Pelcovits A; Olszewski AJ; Decker D; Guyer D; Leblanc TW; Egan P
J Palliat Med; 2022 Apr; 25(4):556-561. PubMed ID: 34842462
[No Abstract] [Full Text] [Related]
42. Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
Lapeyre-Prost A; Perkins G; Vallee M; Pozet A; Tougeron D; Maillet M; Locher C; Dreanic J; Legoux JL; Lièvre A; Lecaille C; Sabate JM; Mary F; Bonnetain F; Jaulmes-Bouillot H; Behal F; Landi B; Taieb J
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101709. PubMed ID: 33930588
[TBL] [Abstract][Full Text] [Related]
43. Performance of care for end-of-life cancer patients in Tuscany: The interplay between place of care, aggressive treatments, opioids, and place of death. A retrospective cohort study.
Ferrè F; Vinci B; Murante AM
Int J Health Plann Manage; 2019 Oct; 34(4):1251-1264. PubMed ID: 30994208
[TBL] [Abstract][Full Text] [Related]
44. High-Intensity End-of-Life Care Among Patients With GI Cancer in Puerto Rico: A Population-Based Study.
Ortiz-Ortiz KJ; Tortolero-Luna G; Torres-Cintrón CR; Zavala-Zegarra DE; Gierbolini-Bermúdez A; Ramos-Fernández MR
JCO Oncol Pract; 2021 Feb; 17(2):e168-e177. PubMed ID: 33567240
[TBL] [Abstract][Full Text] [Related]
45. Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006.
Tang ST; Wu SC; Hung YN; Chen JS; Huang EW; Liu TW
J Clin Oncol; 2009 Sep; 27(27):4613-8. PubMed ID: 19704067
[TBL] [Abstract][Full Text] [Related]
46. Healthcare Utilization is High in Adult Patients Relapsing after Allogeneic Hematopoietic Cell Transplantation.
Langston JA; Sundaram V; Periyakoil VS; Muffly L
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1659-1665. PubMed ID: 30959162
[TBL] [Abstract][Full Text] [Related]
47. The economic burden of end-of-life care in metastatic breast cancer.
Bramley T; Antao V; Lunacsek O; Hennenfent K; Masaquel A
J Med Econ; 2016 Nov; 19(11):1075-1080. PubMed ID: 27248201
[TBL] [Abstract][Full Text] [Related]
48. Comparison of medical outcomes and health care costs at the end of life between dialysis patients with and without cancer: a national population-based study.
Chiang JK; Chen JS; Kao YH
BMC Nephrol; 2019 Jul; 20(1):265. PubMed ID: 31311518
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of Family Characteristics and Multiple Hospitalizations at the End of Life: Evidence from the Utah Population Database.
Tay DL; Ornstein KA; Meeks H; Utz RL; Smith KR; Stephens C; Hashibe M; Ellington L
J Palliat Med; 2022 Mar; 25(3):376-387. PubMed ID: 34448596
[No Abstract] [Full Text] [Related]
50. Chemotherapy Use in the Months Before Death and Estimated Costs of Care in the Last Week of Life.
Garrido MM; Prigerson HG; Bao Y; Maciejewski PK
J Pain Symptom Manage; 2016 May; 51(5):875-881.e2. PubMed ID: 26899821
[TBL] [Abstract][Full Text] [Related]
51. Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non-Small-Cell Lung Cancer: A Population-Based Study in Taiwan.
Tsai HY; Chung KP; Kuo RN
J Pain Symptom Manage; 2018 Mar; 55(3):798-807.e4. PubMed ID: 29056563
[TBL] [Abstract][Full Text] [Related]
52. Quality of End-of-Life Care for People with Advanced Non-Small Cell Lung Cancer in Ontario: A Population-Based Study.
Goldie CL; Nguyen P; Robinson AG; Goldie CE; Kircher CE; Hanna TP
Curr Oncol; 2021 Aug; 28(5):3297-3315. PubMed ID: 34590598
[TBL] [Abstract][Full Text] [Related]
53. End-of-life intravenous chemotherapy administration patterns in the treatment of Queensland lung and pancreas cancer patients: a 10-year retrospective analysis.
Allen MJ; Dunn N; Guan T; Harrington J; Walpole E
Intern Med J; 2022 Apr; 52(4):623-632. PubMed ID: 33070428
[TBL] [Abstract][Full Text] [Related]
54. Hospital end-of-life treatment intensity among cancer and non-cancer cohorts.
Barnato AE; Cohen ED; Mistovich KA; Chang CC
J Pain Symptom Manage; 2015 Mar; 49(3):521-9.e1-5. PubMed ID: 25135656
[TBL] [Abstract][Full Text] [Related]
55. Quality of End-of-Life Care in Gastrointestinal Cancers: A 13-Year Population-Based Retrospective Analysis in Ontario, Canada.
Lees CS; Seow H; Chan KK; Gayowsky A; Sinnarajah A
Curr Oncol; 2022 Nov; 29(12):9163-9171. PubMed ID: 36547131
[TBL] [Abstract][Full Text] [Related]
56. Association between survival time with metastatic breast cancer and aggressive end-of-life care.
Accordino MK; Wright JD; Vasan S; Neugut AI; Gross T; Hillyer GC; Hershman DL
Breast Cancer Res Treat; 2017 Nov; 166(2):549-558. PubMed ID: 28752188
[TBL] [Abstract][Full Text] [Related]
57. Patient beliefs that chemotherapy may be curative and care received at the end of life among patients with metastatic lung and colorectal cancer.
Mack JW; Walling A; Dy S; Antonio AL; Adams J; Keating NL; Tisnado D
Cancer; 2015 Jun; 121(11):1891-7. PubMed ID: 25677655
[TBL] [Abstract][Full Text] [Related]
58. Aggressive end-of-life care across gradients of cognitive impairment in nursing home patients with metastatic cancer.
Koroukian SM; Douglas SL; Vu L; Fein HL; Gairola R; Warner DF; Schiltz NK; Cullen J; Owusu C; Sajatovic M; Rose J
J Am Geriatr Soc; 2023 Nov; 71(11):3546-3553. PubMed ID: 37515440
[TBL] [Abstract][Full Text] [Related]
59. End-of-life discussions reduce the utilization of life-sustaining treatments during the last three months of life in cancer patients.
Chan SY; Lai YJ; Chen YY; Chiang SJ; Tsai YF; Hsu LF; Chuang PH; Chen CC; Yen YF
Sci Rep; 2022 May; 12(1):7477. PubMed ID: 35523935
[TBL] [Abstract][Full Text] [Related]
60. Does Increasing Home Care Nursing Reduce Emergency Department Visits at the End of Life? A Population-Based Cohort Study of Cancer Decedents.
Seow H; Barbera L; Pataky R; Lawson B; O'Leary E; Fassbender K; McGrail K; Burge F; Brouwers M; Sutradhar R
J Pain Symptom Manage; 2016 Feb; 51(2):204-12. PubMed ID: 26514717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
